Law360
Assessing FDA Pathways For Genome-Edited Plant Foods
March 21, 2024
In February, the U.S. Food and Drug Administration clarified the regulatory pathway for foods produced from genome-edited plants in the form of a final guidance issued by the agency's Center for Food Safety and Applied Nutrition and Center for Veterinary Medicine, titled "Foods Derived from Plants Produced Using Genome Editing." In this article, Sidley analyzes the paths forward that are available.
連絡先
得意分野
Suggested News & Insights
A New World Order – Market Access, MFN, and GeopoliticsTuesday, November 10, 2026Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026Sidley Wins Seven Honors at the 2026 LMG Life Sciences Americas AwardsSeptember 11, 2026Sidley Represents Vegamour in Its Acquisition by Belle BrandsSeptember 9, 2026When AI Changes The Deal: Seven AI-related Considerations for Life Sciences M&A DealmakersSeptember 8, 2026New York Ethics Opinion Warns Lawyers on Qui Tam DeceptionSeptember 2, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

